Speaker illustration

Doctor Pedro Moliner

Bellvitge University Hospital, Hospitalet De Llobregat (Spain)

Member of:

European Society of Cardiology
Heart Failure Association

Pedro Moliner MD PhD, is consultant cardiologist in South Metropolitan Barcelona Integrated Heart Failure Programme and Cardio-Oncology Unit, Bellvitge University Hospital, Barcelona. Postdoctoral researcher in the BIO-HEART Cardiovascular diseases research group, IDIBELL (Bellvitge Biomedical Research Institute). He is member of the Council of Cardio-Oncology of the Spanish Society of Cardiology and the European Society of Cardiology, and also certified board of the International Cardio-Oncology Society. Dr. Moliner is the current director of the Cardio-Oncology Unit at the HUB-ICO Campus. This is a multidisciplinary unit created as a joint effort between Bellvitge University Hospital and Catalan Institute of Oncology to provide comprehensive cardiovascular care to patients with cancer.

Causes of death in a heart failure clinic in Spain along 17 years

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Real world heart failures populations

Thumbnail

Multimarker panel of cardiac biomarkers in patients with heart failure and mid-range ejection fraction

Event: ESC CONGRESS 2017

Topic: Heart failure, other

Session: Best Posters in HFpEF

Thumbnail

Prognostic value of a panel of biomarkers in heart failure with mid-range ejection fraction

Event: ESC CONGRESS 2017

Topic: Prognosis

Session: Chronic heart failure (CHF)

Thumbnail

Frailty, co-morbidities and survival in heart failure patients with mid-range ejection fraction

Event: ESC CONGRESS 2017

Topic: Heart failure, other

Session: Acute heart failure (AHF)

Thumbnail

Biomarker profiling in heart failure with mid-range ejection fraction

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Biomarkers, other

Session: Moderated Poster session 3 - Diagnosis

Thumbnail

This platform is supported by

logo Novo Nordisk